InsidersTradesSigma
Follow the 인벤테라 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 인벤테라 has logged 8 reports. Market capitalisation: €60.6bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: 신태현. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Inventaera es una empresa de salud y farmacéutica que cotiza en el XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.